Stay updated on Low Dose Sulindac & Eflornithine for FAP Clinical Trial
Sign up to get notified when there's something new on the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page.

Latest updates to the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page
- Check3 days agoChange DetectedThe page's revision indicator was updated from v3.6.4 to v3.6.5, signaling a deployment of a new site version. No study content appears to be affected by this change.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe revision label was updated from v3.6.3 to v3.6.4. This indicates a newer system revision without changes to the study details or visible content.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedThe revision string on the page was updated from v3.6.2 to v3.6.3, signaling a small update to the page content or formatting rather than substantive changes to the study information.SummaryDifference0.1%

- Check46 days agoChange DetectedVersion tag updated from v3.6.0 to v3.6.2 on the page, signaling an update to the page template or backend. No substantive content edits are shown in the provided changes.SummaryDifference0.1%

- Check60 days agoChange DetectedNew study-record help sections were added: How to Read a Study Record, Common Questions, How to Join a Study, and a standardized Intervention/Treatment label. The old label Intervention / Treatment and the earlier Revision: v3.5.5 note were removed, and the revision line now shows Revision: v3.6.0.SummaryDifference0.9%

- Check67 days agoChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, indicating a minor backend or formatting update to the page. No study content, eligibility criteria, or results appear to be altered by this revision.SummaryDifference0.1%

Stay in the know with updates to Low Dose Sulindac & Eflornithine for FAP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page.